FDA-Inspected Site

Advanced Therapies LLC

11 FDA inspections are on record for Advanced Therapies LLC in Philadelphia, United States.

Clean· No action indicated

Philadelphia, United States · Last updated August 15, 2026

Overview

  • 11 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-11-25.

At a glance

Inspections

11

Form 483s

2

EIRs

6

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Nov 2025 – 25 Nov 2025BiologicsClean
4 Feb 2025 – 7 Feb 2025Human DrugsClean
28 Aug 2023 – 1 Sep 2023Biologics483On file
14 Jan 2020 – 22 Jan 2020Human DrugsClean
13 Apr 2015 – 17 Apr 2015Human Drugs483View 483 →
11 Sep 2013 – 12 Sep 2013BiologicsClean
24 Aug 2012Not recordedClean
6 Jan 2010Not recordedClean
16 Jul 2008Not recordedClean
3 Jun 2004Not recordedClean
27 Dec 2002Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

17 Apr 2015
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Anastasia M Shields, Ko U Min, Gayle S Lawson

17 Apr 2015
21 CFR 211.194(a)

Complete test data included in records

Cited by Anastasia M Shields, Ko U Min, Gayle S Lawson

17 Apr 2015
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Anastasia M Shields, Ko U Min, Gayle S Lawson

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Advanced Therapies LLC's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat